Silvercrest Asset Management’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,603	Closed	-$331K	–	804
2024 Q2	$331K	Sell	1,603 -6,513	-80%	-$1.48M	﹤0.01%	799
2024 Q1	$2.2M	Buy	8,116 +912	+13%	+$218K	0.01%	501
2023 Q4	$1.7M	Buy	7,204 +436	+6%	+$85.7K	0.01%	518
2023 Q3	$1.33M	Buy	6,768 +439	+7%	+$90.1K	0.01%	547
2023 Q2	$1.33M	Buy	6,329 +1,123	+22%	+$223K	0.01%	541
2023 Q1	$1.05M	Buy	5,206 +164	+3%	+$37.2K	0.01%	573
2022 Q4	$1.1M	Sell	5,042 -244	-5%	-$53.3K	0.01%	563
2022 Q3	$1.04M	Buy	+5,286	New	+$1.14M	0.01%	548
2022 Q1	–	Sell	-590	Closed	-$222K	–	856
2021 Q4	$222K	Sell	590 -50	-8%	-$19.4K	﹤0.01%	785
2021 Q3	$264K	Hold	640	–	–	﹤0.01%	773
2021 Q2	$237K	Buy	+640	New	+$214K	﹤0.01%	785